Search research articles
Contact Us
Filters
Showing results (81-90 of 173) with videos related to
Page
of 18
Sort By:
The Annals of Pharmacotherapy
|
June 6, 2013
Posaconazole therapeutic drug monitoring in pediatric patients and young adults with cancer
Valeria A Bernardo, Shane J Cross, Kristine R Crews, et al.
Oncotarget
|
November 9, 2018
Genome-wide association analysis identifies SNPs predictive of <i>in vitro</i> leukemic cell sensitivity to cytarabine in pediatric AML
Salma A Bargal, Roya Rafiee, Kristine R Crews, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2002
Altered irinotecan pharmacokinetics in pediatric high-grade glioma patients receiving enzyme-inducing anticonvulsant therapy
Kristine R Crews, Clinton F Stewart, Dana Jones-Wallace, et al.
Cancer Medicine
|
July 26, 2020
Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia
Seth E Karol, Yilun Sun, Li Tang, et al.
Pharmacogenomics
|
December 15, 2016
The impact of the UGT1A1*60 allele on bilirubin serum concentrations
Amy L Pasternak, Kristine R Crews, Kelly E Caudle, et al.
ACS Chemical Neuroscience
|
December 6, 2013
Acute and chronic mu opioids differentially regulate thrombospondins 1 and 2 isoforms in astrocytes
Ellen Phamduong, Maanjot K Rathore, Nicholas R Crews, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2004
Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors
Lars M Wagner, Kristine R Crews, Lisa C Iacono, et al.
Clinical Biochemistry
|
May 13, 2026
G6PD activity in pediatric patients with the G6PD Ilesha variant: A case series G6PD Ilesha variant in Pediatric patients
Katherine M Robinson, Meghan D McNulty, Kristine R Crews, et al.
Clinical Pharmacology and Therapeutics
|
September 13, 2016
An Inherited Genetic Variant in CEP72 Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia
W Stock, B Diouf, K R Crews, et al.
Annual Review of Pharmacology and Toxicology
|
October 9, 2014
Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers
Henry M Dunnenberger, Kristine R Crews, James M Hoffman, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 173) with videos related to
Sort By:
Page
of 18
The Annals of Pharmacotherapy
|
June 6, 2013
Posaconazole therapeutic drug monitoring in pediatric patients and young adults with cancer
Valeria A Bernardo, Shane J Cross, Kristine R Crews, et al.
Oncotarget
|
November 9, 2018
Genome-wide association analysis identifies SNPs predictive of <i>in vitro</i> leukemic cell sensitivity to cytarabine in pediatric AML
Salma A Bargal, Roya Rafiee, Kristine R Crews, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2002
Altered irinotecan pharmacokinetics in pediatric high-grade glioma patients receiving enzyme-inducing anticonvulsant therapy
Kristine R Crews, Clinton F Stewart, Dana Jones-Wallace, et al.
Cancer Medicine
|
July 26, 2020
Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia
Seth E Karol, Yilun Sun, Li Tang, et al.
Pharmacogenomics
|
December 15, 2016
The impact of the UGT1A1*60 allele on bilirubin serum concentrations
Amy L Pasternak, Kristine R Crews, Kelly E Caudle, et al.
ACS Chemical Neuroscience
|
December 6, 2013
Acute and chronic mu opioids differentially regulate thrombospondins 1 and 2 isoforms in astrocytes
Ellen Phamduong, Maanjot K Rathore, Nicholas R Crews, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2004
Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors
Lars M Wagner, Kristine R Crews, Lisa C Iacono, et al.
Clinical Biochemistry
|
May 13, 2026
G6PD activity in pediatric patients with the G6PD Ilesha variant: A case series G6PD Ilesha variant in Pediatric patients
Katherine M Robinson, Meghan D McNulty, Kristine R Crews, et al.
Clinical Pharmacology and Therapeutics
|
September 13, 2016
An Inherited Genetic Variant in CEP72 Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia
W Stock, B Diouf, K R Crews, et al.
Annual Review of Pharmacology and Toxicology
|
October 9, 2014
Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers
Henry M Dunnenberger, Kristine R Crews, James M Hoffman, et al.
Page
of 18